Bibliography
- European Pharmacopoeia Commission. Oromucosal Preparations. In: European Pharmacopoeia. 8th ed. Strasbourg: European Directorate for the Quality of Medicines (EDQM); 2014.
- Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8:299–316.
- Preis M, Woertz C, Schneider K, et al. Design and evaluation of bilayered buccal film preparations for local administration of lidocaine hydrochloride. Eur J Pharm Biopharm. 2014;86:552–561.
- Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci. 2015;75:2–9.
- Visser JC, Woerdenbag HJ, Crediet S, et al. Orodispersible films in individualized pharmacotherapy: the development of a formulation for pharmacy preparations. Int J Pharm. 2015;478:155–163.
- Garsuch V, Breitkreutz J. Novel analytical methods for the characterization of oral wafers. Eur J Pharm Biopharm. 2009;73:195–201.
- Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94–107.
- Sekhar KC, Naidu KVS, Vishnu YV, et al. Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches. Drug Deliv. 2008;15:185–191.
- Kianfar F, Chowdhry BZ, Antonijevic MD, et al. Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs. Drug Dev Ind Pharm. 2012;38:1207–1220.
- Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77:187–199.
- Low AQ, Parmentier J, Khong YM, et al. Effect of type and ratio of solubilising polymer on characteristics of hot-melt extruded orodispersible films. Int J Pharm. 2013;455:138–147.
- Palem CR, Battu SK, Maddineni S, et al. Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology. Pharm Dev Technol. 2013;18:186–195.
- Repka MA, Prodduturi S, Stodghill SP. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm. 2003;29:757–765.
- Genina N, Janβen EM, Breitenbach A, et al. Evaluation of different substrates for inkjet-printing of rasagiline mesylates substrates. Eur J Pharm Biophar. 2013;85:1075–1083.
- Preis M, Breitkreutz J, Sandler N. Perspective: concepts of printing technologies for oral film formulations. Int J Pharm. 2015. Epub 2015 Feb 13. DOI:10.1016/j.ijpharm.2015.1002.1032.
- Janßen EM, Schliephacke R, Breitenbach A, et al. Drug-printing by flexographic printing technology – a new manufacturing process for orodispersible films. Int J Pharm. 2013;441:818–825.
- Stegemann S. Challenges and opportunities in the design of age-appropriate drug products. Z Gerontol Geriat. 2012;45:479–484.
- Schiele J, Quinzler R, Klimm HD, et al. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69:937–948.
- Tanner S, Wells M, Scarbecz M, et al. Drugs: parents’ understanding of and accuracy in using measuring devices to administer liquid oral pain medication. J Am Dent Assoc. 2014;145:141–149.
- Nishigaki M, Kawahara K, Nawa M, et al. Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness. Int J Pharm. 2012;424(1–2):12–17.
- Cram A, Breitkreutz J, Dessetbrethes S, et al. Challenges of developing palatable oral paediatric formulations. Int J Pharm. 2009;365:1–3.
- Bahri-Najafi R, Tavakoli N, Senemar M, et al. Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film. Res Pharm Sci. 2014;9:213–223.
- Daud AS, Sapkal NP, Bonde MN. Development of Zingiber officinale in oral dissolving films: effect of polymers on in vitro, in vivo parameters and clinical efficacy. Asian J Pharmacol. 2011;5:183–189.
- Patel R, Naik S, Patel J, et al. Formulation development and evaluation of mouth melting film of ondansetron. Arch Pharm Sci Res. 2009;1:212–217.
- Singh S, Jain S, Muthu MS, et al. Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS Pharm Sci Tech. 2008;9:660–667.
- Bottenberg P, Cleymaet R, De Muynck C, et al. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991;43:457–464.
- Patel VM, Prajapati BG, Patel JK, et al. Physicochemical characterization and evaluation of buccal adhesive patches containing propranolol hydrochloride. Curr Drug Deliv. 2006;3:325–331.
- Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: in vitro/in vivo performance. Curr Drug Deliv. 2009;6:17–27.
- Perumal VA, Lutchman D, Mackraj I, et al. Formulation of monolayered films with drug and polymers of opposing solubilities. Int J Pharm. 2008;358:184–191.
- Sharma R. Development of taste masked film of valdecoxib for oral use. Indian J Pharm Sci. 2007;69:320–323.
- Smart JD. Buccal drug delivery. Expert Opin Drug Deliv. 2005;2:507–517.
- Strickley RG, Iwata Q, Wu S, et al. Pediatric drugs – a review of commercially available oral formulations. J Pharm Sci. 2008;97:1731–1774.
- Wiet SG, Beyts PK. Sensory characteristics of sucralose and other high intensity sweeteners. J Food Sci. 1992;57:1014–1019.
- Liew K, Tan Y, Peh K. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS Pharm Sci Tech. 2012;13:134–142.
- Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS Pharm Sci Tech. 2008;9:349–356.
- Elmeshad AN, El Hagrasy AS. Characterization and optimization of orodispersible mosapride film formulations. AAPS Pharm Sci Tech. 2011;12:1384–1392.
- Corniello CM. Quick-dissolve strips: from concept to commercialization. Drug Deliv Technol. 2006;6:68–71.
- Slack JP, Brockhoff A, Batram C, et al. Modulation of bitter taste perception by a small molecule hTAS2R antagonist. Curr Biol. 2010;20:1104–1109.
- Preis M, Pein M, Breitkreutz J. Development of a taste-masked orodispersible film containing dimenhydrinate. Pharmaceutics. 2012;4:551–562.
- Li MHC, Krumme M. Edible oral strip or wafer dosage form containing ion exchange resin for taste masking. US20140155483 A1. 2014.
- Hussain MA, Aungst BJ, Koval CA, et al. Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs. Pharm Res. 1988;5:615–618.
- Cilurzo F, Cupone IE, Minghetti P, et al. Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Dev Ind Pharm. 2011;37:252–259.
- Pein M, Preis M, Eckert C, et al. Taste-masking assessment of solid oral dosage forms–a critical review. Int J Pharm. 2014;465:239–254.
- Krampe R, Sieber D, Pein M, et al. A new biorelevant dissolution method for orodispersible films. Eur J Pharm Biopharm. 2015;98:20–25.
- Mohamed MI, Haider M, Ali MAM. Buccal mucoadhesive films containing antihypertensive drug: in vitro/in vivo evaluation. J Chem Pharm Res. 2011;3:665–686.
- Liew KB, Peh KK, Fung Tan YT. Orally disintegrating dosage forms: breakthrough solution for non-compliance. Int J Pharm Pharm Sci. 2013;5:4–8.
- Walsh J, Cram A, Woertz K, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.
- Preis M, Knop K, Breitkreutz J. Mechanical strength test for orodispersible and buccal films. Int J Pharm. 2014;461:22–29.
- Committee for Medicinal Products for Human Use (CHMP), Paediatric Committee (PDCO). Guideline on pharmaceutical development of medicines for paediatric use. London: European Medicines Agency (EMA); 2013. p. 1–24.
- Preis M. Orally disintegrating films and mini-tablets—innovative dosage forms of choice for pediatric use. AAPS Pharm Sci Tech. 2015;16:234–241.
- Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 1999;178:11–22.
- Das NG, Das SK. Development of mucoadhesive dosage forms of buprenorphine for sublingual drug delivery. Drug Deliv. 2004;11:89–95.
- He C, Cui F, Yin L, et al. A polymeric composite carrier for oral delivery of peptide drugs: bilaminated hydrogel film loaded with nanoparticles. Eur Polym J. 2009;45:368–376.
- Avachat AM, Gujar KN, Wagh KV. Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate. Carbohydr Polym. 2013;91:537–542.
- Woertz C, Kleinebudde P. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide. Eur J Pharm Biopharm. 2015;94:52–63.
- Park DM, Song YK, Jee JP, et al. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis. Drug Dev Ind Pharm. 2012;38:1077–1083.
- Kaur G, Singh D, Brar V. Bioadhesive okra polymer based buccal patches as platform for controlled drug delivery. Int J Biol Macromol. 2014;70:408–419.
- Llabot JM, Palma SD, Manzo RH, et al. Design of novel antifungal mucoadhesive films. Part I. Pre-formulation studies. Int J Pharm. 2007;330(1–2):54–60.
- Mukherjee DJ, Bharath S, Madhavan V. Bilayered muco-adhesive delivery system for extended release of bisphosphonates. Int J Phar Bio Sci. 2012;3:304–313.
- Susarla R, Sievens-Figueroa L, Bhakay A, et al. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection. Int J Pharm. 2013;455:93–103.
- Thabet Y. Development of a continuous manufacturing process for double-layer orodispersible films containing cardiovascular drugs for children. European Peadiatric Formulation Initiative Conference; 2014 Sep 17–18; Athens.
- Woertz C, Kleinebudde P. Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability. Intern J Pharm. 2015;493:134–145.
- Upret K, Kumar L, Anand SP, et al. Formulation and evaluation of mouth dissolving films of paracetamol. Int J Pharm Pharm Sci. 2014;6:200–202.
- Rao S, Song Y, Peddie F, et al. Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs. Int J Nanomedicine. 2011;6:1245–1251.
- Shen BD, Shen CY, Yuan XD, et al. Development and characterization of an orodispersible film containing drug nanoparticles. Eur J Pharm Biopharm. 2013;85:1348–1356.
- Morales JO, Huang S, Williams RO, et al. Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery. Colloids Surf B. 2014;122:38–45.
- Jug M, Maestrelli F, Mura P. Native and polymeric β-cyclodextrins in performance improvement of chitosan films aimed for buccal delivery of poorly soluble drugs. J Incl Phenom Macrocycl Chem. 2012;74:87–97.
- Boateng JS, Stevens HNE, Eccleston GM, et al. Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces. Drug Dev Ind Pharm. 2009;35:986–996.
- Skulason S, Asgeirsdottir MS, Magnusson JP, et al. Evaluation of polymeric films for buccal drug delivery. Pharmazie. 2009;64:197–201.
- Puratchikody A, Prasanth VV, Mathew ST, et al. Development and characterization of mucoadhesive patches of salbutamol sulfate for unidirectional buccal drug delivery. Acta Pharm. 2011;61:157–170.
- Heng PWS, Chan LW, Ong KT. Influence of storage conditions and type of plasticizers on ethylcellulose and acrylate films from aqueous dispersions. J Pharm Pharm Sci. 2003;6:334–344.
- Morales JO, Su R, McConville JT. The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films. AAPS Pharm Sci Tech. 2013;14:475–484.
- Nafee NA, Boraie MA, Ismail FA, et al. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003;53:199–212.
- Omidian H, Park K. Hydrogels. In: Siepmann J, Siegel RA, Rathbone MJ, eds. Fundamentals and applications of controlled release drug delivery. New York: Springer; 2012. p. 75–105.
- Miro A, D’Angelo I, Nappi A, et al. Engineering poly(ethylene oxide) buccal films with cyclodextrin: a novel role for an old excipient? Int J Pharm. 2013;452:283–291.
- Preis M, Gronkowsky D, Grytzan D, et al. Comparative study on novel test systems to determine disintegration time of orodispersible films. J Pharm Pharmacol. 2014;66:1102–1111.
- Goel H, Rai P, Rana V, et al. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul. 2008;2:258–274.
- Visser JC, Dohmen WMC, Hinrichs WLJ, et al. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films. Int J Pharm. 2015;485:70–76.
- ICH Q8 International Conference of Harmonization. ICH Guideline: Q8 (R2) Pharmaceutical Development. 2009 [cited 2015 Oct 19]. Available from: http://www.ich.org/products/guidelines/quality/quality-single/article/pharmaceutical-development.html.
- Patel AR, Prajapati DS, Raval JA. Fast dissolving films (FDFs) as a newer venture in fast dissolving dosage forms. Int J Drug Dev Res. 2010;2:232–246.
- Garsuch V, Breitkreutz J. Comparative investigations on different polymers for the preparation of fast-dissolving oral films. J Pharm Pharmacol. 2010;62:539–545.
- Welankiwar A. Photostability testing of pharmaceutical products. Int Res J Pharm. 2013;4:11–15.
- Bouwman-Boer Y, Fenton-May V, Le Brun P, editors. Practical pharmaceutics, an international guideline for the preparation, care and use of medicinal products. Cham: Springer International Publishing AG; 2015.
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Stability testing: photostability testing of new drug substances and products; ICH Guideline Q1b; 1996. p. 1–8.
- Ayensu I, Mitchell JC, Boateng JS. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B. 2012;91(1):258–265.
- Adams G. The principles of freeze-drying. In: Day J, Stacey G, editors. Cryopreservation and freeze-drying protocols. Totowa (NJ): Humana Press; 2007. p. 15–38.
- Fahmy RH, Badr-Eldin SM. Novel delivery approach for ketotifen fumarate: dissofilms formulation using 32 experimental design: in vitro/in vivo evaluation. Pharm Dev Technol. 2014;19:521–530.
- Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharmacia Lettre. 2011;3:152–165.
- Lehrke I, Vollmer U, Maier S. Primary packaging unit for flat administration forms. DE102004056576 A1. 2005.
- Leopold A, Wilson S, Weaver JS, et al. Pharmacokinetics of lidocaine delivered from a transmucosal patch in children. Anesth Prog. 2002;49:82–87.
- Juliano C, Cossu M, Pigozzi P, et al. Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine. AAPS Pharm Sci Tech. 2008;9:1153–1158.
- Nishimura M, Matsuura K, Tsukioka T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368:98–102.
- Kim EY, Lee SY, Jeon JY, et al. Pharmacokinetics of a new orally soluble film formulation of sildenafil administered without water. Int J Clin Pharmacol Ther. 2014;52:437–445.
- Vasisht N, Gever LN, Tagarro I, et al. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study. Clin Drug Investig. 2009;29:647–654.
- Loetsch J, Walter C, Parnham MJ, et al. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet. 2013;52:23–36.
- Vasisht N, Gever LN, Tagarro I, et al. Single-dose pharmacokinetics of fentanyl buccal soluble film. Pain Med. 2010;11:1017–1023.
- Del Consuelo ID, Falson F, Guy RH, et al. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release. 2007;122:135–140.
- Padula C, Pozzetti L, Traversone V, et al. In vitro evaluation of mucoadhesive films for gingival administration of lidocaine. AAPS Pharm Sci Tech. 2013;14:1279–1283.
- Prasanth VV, Puratchikody A, Mathew ST, et al. Effect of permeation enhancers in the mucoadhesive buccal patches of salbutamol sulphate for unidirectional buccal drug delivery. Res Pharm Sci. 2014;9:259–268.
- Aungst BJ. Oral mucosal permeation enhancement: possibilities and limitations. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Taylor & Francis; 1996. p. 65–83.
- Lu MYF, Hui HW. Delivery of renin inhibitor through mouth mucosa. Drug Dev Ind Pharm. 1996;22:1167–1171.
- Reiner V, Giarratana N, Monti NC, et al. Rapidfilm®: an innovative pharmaceutical form designed to improve patient compliance. Int J Pharm. 2010;393:55–60.